The European Medicines Agency recommended conditional approval Monday for a coronavirus vaccine developed by BioNTech and Pfizer to be used across the European Union, weeks after the shot was first authorized in Britain and the United States.
The European Medicines Agency recommended conditional approval Monday for a coronavirus vaccine developed by BioNTech and Pfizer to be used across the European Union, weeks after the shot was first authorized in Britain and the United States.